F S&P 500
5,310.50 +6.50 (+0.12%) F Dow Jones
38,836.00 +49.00 (+0.13%) F Nasdaq
18,754.75 +53.75 (+0.29%) E-mini Russell 2000 Index Futur
2,040.20 +2.70 (+0.13%) Petróleo
73.13 -0.12 (-0.16%) Oro
2,352.20 +4.80 (+0.20%)
Tissue Repair Ltd (TRP.AX)
Tissue Repair Ltd
255 Pitt Street
Level 10
Sydney, NSW 2000
Australia
61 427 985 805
https://www.tissuerepair.com.au
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Tony Charara | Co-Founder & Executive Director | 100k | N/D | N/D |
| Mr. Cameron Jones C.A. | Chief Financial Officer | N/D | N/D | N/D |
| Dr. Darryl Reed | Chief Operating Officer | N/D | N/D | N/D |
| Ms. Sushma Kejriwal | Company Secretary | N/D | N/D | N/D |
Descripción
Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.
Gestión corporativa
La calificación ISS Governance QuickScore de Tissue Repair Ltd a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
